PET/MRI in prostate cancer: a systematic review and meta-analysis.
Laura EvangelistaFabio ZattoniGianluca CassarinoPaolo ArtioliDiego CecchinFabrizio Dal MoroPietro ZucchettaPublished in: European journal of nuclear medicine and molecular imaging (2020)
PET/MRI proved highly sensitive in detecting primary PCa, with a high detection rate for recurrent disease, particularly when radiolabeled PSMA was used.